Anti-Citrullinated Protein Antibody Titers Are Independently Modulated by Both Disease Activity and Conventional or Biologic Anti-Rheumatic Drugs

This study aimed to analyze the factors that influence anti-citrullinated protein antibody (ACPA) titers in a seropositive early arthritis (EA) population under non-protocolized treatment with disease-modifying anti-rheumatic drugs (DMARDs). A total of 130 ACPA-positive patients from the PEARL (Prin...

Descripció completa

Dades bibliogràfiques

Autors principals:	Miren Uriarte Ecenarro, Daniel Useros, Aranzazu Alfranca, Reyes Tejedor, Isidoro González-Alvaro, Rosario García-Vicuña
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-07-01
Col·lecció:	Diagnostics
Matèries:	early arthritis Rheumatoid arthritis ACPA biomarkers disease activity disease-modifying anti-rheumatic drugs (DMARDs)
Accés en línia:	https://www.mdpi.com/2075-4418/12/7/1773
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!